nitric oxide-donating compounds (EyePoint/NicOx)

N/A

Report date: 2025/01/26 16:44:30
NME

Base Information

Drug Namenitric oxide-donating compounds (EyePoint/NicOx)
Drug Alias Namenitric oxide-donating compounds (pSivida/NicOx)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donors
TargetsUpdating
Therapy Area/IndicationsGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEyepoint Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNicox SAEyepoint Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A